The talks are in early stages, and there’s no guarantee a deal will be reached, the Journal reported July 28.
Any deal reached would be fairly substantial, as Hillrom has a market value of roughly $8 billion, according to the Journal. Baxter, based in Deerfield, Ill., has a market value of approximately $41 billion.
People familiar with the matter told the Journal that Hillrom already has refused a $144-per-share offer from Baxter.
Chicago-based Hillrom makes medical equipment, including hospital beds and patient-monitoring devices.
Becker’s Hospital Review has reached out to both Baxter and Hillrom for comment and will update this story accordingly.
Read the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
